In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
Plant-based artificial Christmas trees set to launch this December
In California, artificial Christmas tree maker Balsam Brands will launch a new line of trees for 2025’s holiday season that use needles made of...
Artist Sam Shoemaker takes mushroom kayak on twelve-hour journey
In California, an artist and “mycologist” has crossed 26 miles of ocean in a kayak made of mycelium, the root system of mushrooms.
Sam...
Canadian funeral group becomes first to offer Loop’s mycelium coffins and urns
In Canada, Mount Pleasant Group’s Meadowvale Cemetery, Funeral and Cremation Centres have become the first in Canada to offer the Loop Living Cocoon and...